← Back to patent-cliff list
CAS 59858-41-2
2-(Diethylamino)acetyl chloride
Codes: Lidocaine Hydrochloride-012
Application context (from source-drug indications)
Premature ejaculationLidocaine/Prilocaine cutaneous sprayPhysiological sexual dysfunctionLidocaine/Prilocaine cutaneous sprayTrichomoniasisMiconazole/Metronidazole/LidocaineCandidiasisMiconazole/Metronidazole/LidocaineVaginitisMiconazole/Metronidazole/LidocaineArrhythmiaLidocaine HydrochlorideAnaesthesiaLidocaine HydrochlorideVentricular tachycardiaLidocaine HydrochloridePostoperative complicationLidocaine HydrochloridePelvic organ prolapseLidocaine HydrochlorideStress urinary incontinenceLidocaine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lidocaine/Prilocaine cutaneous spray | Tier C — Watch / trade | - |
| Miconazole/Metronidazole/Lidocaine | Tier C — Watch / trade | - |
| Lidocaine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Lidocaine/Prilocaine cutaneous sprayProcess routesteps: 8total yield: 93.4kg(Lidocaine Hydrochloride (API))
1,3-Dimethyl-2-nitrobenzene→2-Amino-1,3-dimethylbenzene→2-Bromanylethanoic acid→2-Chloroacetic acid→2-Chloranylethanoyl chloride→2-Chloroacetic acid methyl ester→2-Bromo-N-(2,6-dimethylphenyl)acetamide→1-Chloroacetylamino-2,6-dimethylbenzene→N-Ethylethanamine→2-Diethylamino-N-(2,6-dimethylphenyl)acetamide→2-(Diethylamino)acetic acid→2-(Diethylamino)acetyl chloride→Methyl 2-(diethylamino)acetate→3-(2-Methoxyphenyl)-1H-pyrazole→2-(Chloromethyl)pyridine hydrochloride→Lidocaine Hydrochloride-016→Dichloridomanganese 2-[[3-(2-methoxyphenyl)-1H-pyrazol-1-yl]methyl]pyridine
Miconazole/Metronidazole/LidocaineProcess routesteps: 8total yield: 93.4kg(Lidocaine Hydrochloride (API))
1,3-Dimethyl-2-nitrobenzene→2-Amino-1,3-dimethylbenzene→2-Bromanylethanoic acid→2-Chloroacetic acid→2-Chloranylethanoyl chloride→2-Chloroacetic acid methyl ester→2-Bromo-N-(2,6-dimethylphenyl)acetamide→1-Chloroacetylamino-2,6-dimethylbenzene→N-Ethylethanamine→2-Diethylamino-N-(2,6-dimethylphenyl)acetamide→2-(Diethylamino)acetic acid→2-(Diethylamino)acetyl chloride→Methyl 2-(diethylamino)acetate→3-(2-Methoxyphenyl)-1H-pyrazole→2-(Chloromethyl)pyridine hydrochloride→Lidocaine Hydrochloride-016→Dichloridomanganese 2-[[3-(2-methoxyphenyl)-1H-pyrazol-1-yl]methyl]pyridine
1,3-Dimethyl-2-nitrobenzene→2-Amino-1,3-dimethylbenzene→2-Bromanylethanoic acid→2-Chloroacetic acid→2-Chloranylethanoyl chloride→2-Chloroacetic acid methyl ester→2-Bromo-N-(2,6-dimethylphenyl)acetamide→1-Chloroacetylamino-2,6-dimethylbenzene→N-Ethylethanamine→2-Diethylamino-N-(2,6-dimethylphenyl)acetamide→2-(Diethylamino)acetic acid→2-(Diethylamino)acetyl chloride→Methyl 2-(diethylamino)acetate→3-(2-Methoxyphenyl)-1H-pyrazole→2-(Chloromethyl)pyridine hydrochloride→Lidocaine Hydrochloride-016→Dichloridomanganese 2-[[3-(2-methoxyphenyl)-1H-pyrazol-1-yl]methyl]pyridine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.